MarketReportsOnline.com - Global Hemophilia Market Report 2012 Edition
Published: June 2012 No. of Pages: 47
Price: Single User: US $ 800 Corporate User: US $ 1600
With an ever changing technological environment and an unstable economic scenario, many scientific studies are being conducted which are leading to the discovery of new coagulation factors, proteins and plasma concentrates used for treating chronic diseases and medical conditions. The market for hemophilia products has shown continuous growth in the past years growing at a CAGR of around 8.96% during 2006-11 and is projected to expand steadily in the years to come.
The occurrence rate of bleeding disorders such as hemophilia is increasing, calling for an increased usage of blood plasma products. The male population of the world is rising and males are the ones who are worst affected by hemophilia as they carry only one X chromosome. Females are only the carriers of this disease. Furthermore, the increasing expenditure is also responsible for higher utilization of recombinant and plasma derived coagulation factors. The existing treatments for hemophilia treatment comprise of blood plasma derivatives and recombinant factors.
The leading players in the hemophilia treatment market include: Baxter, Grifols, Pfizer and Novo Nordisk, among others, competing mainly on the basis of product pricing and performance, supply of the products, and continuous offering of new and innovative protein and blood plasma derivatives. Apart from this, the presence of several players operating at domestic level, emergence of new players, and agreements with government agencies, academic and research institutions make the therapeutic landscape of hemophilia market fiercely competitive.
The key trends in the hemophilia treatment market are the increasing inclination towards prophylaxis, limiting the use of central venous access device for prophylactic treatment, development of long-acting Factor VIII and IX, deep penetration of rFVIII products within the emerging markets. The recent developments in the respective field include gene therapy for treating hemophilia B, half life extension of the recombinant coagulation factors, development of 4-factor PCC for reversal of vitamin K antagonist anticoagulant therapy along with recent approval of ADVATE in China apart from other clinical trials on run.
The major factors driving the growth of the industry are the increasing number of new patients registering themselves for treatment at the hospitals and other healthcare institutions, growing male population, rising expenditure on healthcare globally, and the increased life expectancy for hemophilia patients.
Although this industry has been witnessing an aggressive growth with latest technological advancements, still there are factors like antibody neutralization and lack of diagnostic facilities leading to improper or late detection of the disease, which are posing acute challenges in front of every other person falling within the realm of this therapeutic field.
The report provides an analysis of the global hemophilia treatment market. It also discusses the major trends, growth drivers and potential markets. The report presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.
By combining SPSS Inc.s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Global Hemophilia Market Report 2012 Edition
Table Of contents
1. Hemophilia: An Overview
2. Market Overview
3. Hemophilia Market Dynamics
4. Hemophilia Market - Competitive Scenario
5. Company Profiles
6. Market Outlook
List of Tables
List of Charts